98 related articles for article (PubMed ID: 1334159)
1. FDA Committee recommends combined DTP, Haemophilus influenzae vaccine.
Marwick C
JAMA; 1992 Dec 23-30; 268(24):3415. PubMed ID: 1334159
[No Abstract] [Full Text] [Related]
2. Administration of two vaccines, DTP and Hib, in one single injection.
De Bont B
Acta Clin Belg; 1995; 50(4):246-7. PubMed ID: 7483978
[No Abstract] [Full Text] [Related]
3. Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine.
Eskola J; Olander RM; Hovi T; Litmanen L; Peltola S; Käyhty H
Lancet; 1996 Dec 21-28; 348(9043):1688-92. PubMed ID: 8973430
[TBL] [Abstract][Full Text] [Related]
4. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
Dashefsky B; Wald E; Guerra N; Byers C
Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
[TBL] [Abstract][Full Text] [Related]
5. ACIP releases recommendations on the combined DTP and Hib vaccine. Advisory Committee on Immunization Practices.
Am Fam Physician; 1994 Feb; 49(2):501, 505. PubMed ID: 8304266
[No Abstract] [Full Text] [Related]
6. From the Centers for Disease Control and Prevention. FDA approval of use of a new Haemophilus b conjugate vaccine and a combined diphtheria-tetanus-pertussis and Haemophilus b conjugate vaccine for infants and children.
JAMA; 1993 May; 269(18):2359. PubMed ID: 8479054
[No Abstract] [Full Text] [Related]
7. Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period.
Miller MA; Meschievitz CK; Ballanco GA; Daum RS
Pediatrics; 1995 Apr; 95(4):522-7. PubMed ID: 7700752
[TBL] [Abstract][Full Text] [Related]
8. Expert panel convened by FDA recommends Haemophilus influenzae type B vaccine should continue in use for children older than 2 years.
Marwick C
JAMA; 1987 Jun; 257(23):3182-3. PubMed ID: 3495673
[No Abstract] [Full Text] [Related]
9. Current status of pediatric vaccines.
Feldman WE
Postgrad Med; 1991 Oct; 90(5):135-6, 139-40. PubMed ID: 1833727
[TBL] [Abstract][Full Text] [Related]
10. [Vaccine against Haemophilus influenzae type b--antibody response and adverse effects].
Nøkleby H; Sandbu S; Käyhty H; Olander RM; Heilmann C
Tidsskr Nor Laegeforen; 1995 May; 115(13):1604-6. PubMed ID: 7778073
[TBL] [Abstract][Full Text] [Related]
11. Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis.
Eskola J; Ward J; Dagan R; Goldblatt D; Zepp F; Siegrist CA
Lancet; 1999 Dec; 354(9195):2063-8. PubMed ID: 10636384
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants.
Punjabi NH; Richie EL; Simanjuntak CH; Harjanto SJ; Wangsasaputra F; Arjoso S; Rofiq A; Prijanto M; Julitasari ; Yela U; Herzog C; Cryz SJ
Vaccine; 2006 Mar; 24(11):1776-85. PubMed ID: 16303216
[TBL] [Abstract][Full Text] [Related]
13. Safety and immunogenicity of a Haemophilus influenzae type B polysaccharide-tetanus toxoid conjugate vaccine combined with diphtheria, tetanus and pertussis vaccines in Thai infants.
Chotpitayasunondh T; Panpitpat C; Thisyakorn U; Furer E; Que JU; Hasler T; Cryz SJ
Southeast Asian J Trop Med Public Health; 1997 Mar; 28(1):91-8. PubMed ID: 9322290
[TBL] [Abstract][Full Text] [Related]
14. [Encephalitis after simultaneous DPT and oral trivalent poliomyelitis (Sabin vaccine) and HiB preventive vaccination?].
Wiersbitzky S; Schröder C; Griefahn B; Käding M; Wiersbitzky H; Anders C; Seidel W; Mendel R
Kinderarztl Prax; 1993 Jun; 61(4-5):172-3. PubMed ID: 8103131
[No Abstract] [Full Text] [Related]
15. FDA approval of use of a new Haemophilus b conjugate vaccine and a combined diphtheria-tetanus-pertussis and Haemophilus b conjugate vaccine for infants and children.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1993 Apr; 42(15):296-8. PubMed ID: 8479415
[No Abstract] [Full Text] [Related]
16. Validating current immunization practice with young infants.
Lewis M; Ramsay DS; Suomi SJ
Pediatrics; 1992 Nov; 90(5):771-3. PubMed ID: 1408553
[No Abstract] [Full Text] [Related]
17. FDA workshop on Haemophilus b polysaccharide vaccine--a preliminary report.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1987 Aug; 36(32):529-31. PubMed ID: 3112543
[No Abstract] [Full Text] [Related]
18. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content.
Hla KH; Thein SA; Aye A; Han HH; Bock HL; David MP; Schuerman L
Pediatr Infect Dis J; 2006 Aug; 25(8):706-12. PubMed ID: 16874170
[TBL] [Abstract][Full Text] [Related]
19. Vaccination coverage of 2-year-old children--United States, 1992-1993.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1994 Apr; 43(15):282-3. PubMed ID: 8164635
[TBL] [Abstract][Full Text] [Related]
20. From the Centers for Disease Control and Prevention. Childhood vaccines--United States, 1995-1999.
JAMA; 2001 Dec; 286(24):3073-4. PubMed ID: 11787489
[No Abstract] [Full Text] [Related]
[Next] [New Search]
